Company · CIK 0001730430 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Kiniksa Pharmaceuticals International, plc · KNSA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 SForm 4 → | Sep 3, 4:40 pm EDT | Michael R MegnaCHIEF ACCOUNTING OFFICER | 4,600 | $80.30 | $369,380 | 29,062 | −13.7% | 10b5-1 |
| Sep 1, 2026 FMForm 4 → | Sep 3, 4:49 pm EDT | Mark RagosaCHIEF FINANCIAL OFFICER | 13,508 | $79.28 | $349,149 | 20,854 | — | |
| Sep 1, 2026 FMForm 4 → | Sep 3, 4:48 pm EDT | Sanj K PatelCHAIRMAN & CEO, Director | 46,462 | $79.28 | $1,200,616 | 92,348 | — | |
| Sep 1, 2026 FMForm 4 → | Sep 3, 4:46 pm EDT | Sanj K PatelCHAIRMAN & CEO, Director | 46,462 | $79.28 | $1,200,616 | 92,348 | — | |
| Sep 1, 2026 FMForm 4 → | Sep 3, 4:43 pm EDT | John F. PaoliniCHIEF MEDICAL OFFICER | 12,357 | $79.28 | $319,419 | 69,922 | — | |
| Sep 1, 2026 FMForm 4 → | Sep 3, 4:41 pm EDT | Ross MoatCHIEF OPERATING OFFICER | 12,292 | $79.28 | $317,675 | 16,307 | — | |
| Aug 19, 2026 GForm 4 → | Aug 21, 4:35 pm EDT | Barry D QuartDirector | 2,600 | — | — | 12,745 | — | |
| Aug 1, 2026 MForm 4 → | Aug 4, 4:40 pm EDT | Richard S LevyDirector | 403 | — | — | 22,359 | — | |
| Jul 29, 2026 GForm 4 → | Jul 31, 4:34 pm EDT | G Bradley ColeDirector | 4,500 | — | — | 7,172 | — | |
| Jul 29, 2026 SForm 4 → | Jul 31, 4:34 pm EDT | G Bradley ColeDirector | 3,673 | $81.43 | $299,092 | 11,672 | −23.9% | |
| Jul 15, 2026 AFMForm 4 → | Sep 3, 4:40 pm EDT | Michael R MegnaCHIEF ACCOUNTING OFFICER | 17,306 | $77.08 | $447,844 | 33,662 | — | 10b5-1 late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AMForm 4 → | Sep 3, 4:49 pm EDT | Mark RagosaCHIEF FINANCIAL OFFICER | 48,054 | — | — | 0 | — | |
| Sep 1, 2026 AMForm 4 → | Sep 3, 4:48 pm EDT | Sanj K PatelCHAIRMAN & CEO, Director | 181,518 | — | — | 0 | — | |
| Sep 1, 2026 AMForm 4 → | Sep 3, 4:46 pm EDT | Sanj K PatelCHAIRMAN & CEO, Director | 181,518 | — | — | 0 | — | |
| Sep 1, 2026 AMForm 4 → | Sep 3, 4:43 pm EDT | John F. PaoliniCHIEF MEDICAL OFFICER | 41,778 | — | — | 0 | — | |
| Sep 1, 2026 AMForm 4 → | Sep 3, 4:41 pm EDT | Ross MoatCHIEF OPERATING OFFICER | 54,485 | — | — | 0 | — | |
| Sep 1, 2026 AMForm 4 → | Sep 3, 4:40 pm EDT | Michael R MegnaCHIEF ACCOUNTING OFFICER | 29,746 | — | — | 0 | — | 10b5-1 |
| Aug 1, 2026 AMForm 4 → | Aug 4, 4:40 pm EDT | Richard S LevyDirector | 806 | — | — | 0 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 4:42 pm EDT | Dhiraj H MalkaniCHIEF STRATEGY OFFICER | 103,459 | — | — | 0 | — |